| 04/28/2026 3:03 PM | Voyager Therapeutics (1640266) Filer | Form DEFA14A | |
| 04/21/2026 3:05 PM | Voyager Therapeutics (1640266) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/10/2026 3:22 PM | Voyager Therapeutics (1640266) Filer | Form PRE 14A | |
| 04/03/2026 4:55 PM | Sandrock Alfred (1577061) Reporting Voyager Therapeutics (1640266) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/03/2026 4:42 PM | Shiferman Gregory L. (2041689) Reporting Voyager Therapeutics (1640266) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/02/2026 2:53 PM | Sandrock Alfred (1577061) Reporting Voyager Therapeutics (1640266) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/27/2026 1:17 PM | VANGUARD GROUP INC (102909) Filed by Voyager Therapeutics (1640266) Subject | Form SCHEDULE 13G/A | |
| 02/26/2026 8:44 AM | Carter Todd Alfred (1944011) Reporting Voyager Therapeutics (1640266) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/26/2026 8:46 AM | Jorgensen Nathan D. (1842523) Reporting Voyager Therapeutics (1640266) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/26/2026 8:47 AM | Sandrock Alfred (1577061) Reporting Voyager Therapeutics (1640266) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/26/2026 8:48 AM | Swartz Robin (1909636) Reporting Voyager Therapeutics (1640266) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for VYGR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Voyager Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 02/24/2026 4:16 PM | Jorgensen Nathan D. (1842523) Reporting Voyager Therapeutics (1640266) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/24/2026 4:17 PM | Carter Todd Alfred (1944011) Reporting Voyager Therapeutics (1640266) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/18/2026 3:15 PM | Sandrock Alfred (1577061) Reporting Voyager Therapeutics (1640266) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/18/2026 2:45 PM | Swartz Robin (1909636) Reporting Voyager Therapeutics (1640266) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/18/2026 10:15 AM | ARMISTICE CAPITAL, LLC (1601086) Filed by Voyager Therapeutics (1640266) Subject | Form SCHEDULE 13G/A | |
| 02/17/2026 5:21 PM | EcoR1 Capital, LLC (1587114) Filed by Voyager Therapeutics (1640266) Subject | Form SCHEDULE 13G/A | |
| 02/12/2026 7:00 AM | Voyager Therapeutics (1640266) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/11/2026 3:30 PM | Sandrock Alfred (1577061) Reporting Voyager Therapeutics (1640266) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 3:32 PM | Swartz Robin (1909636) Reporting Voyager Therapeutics (1640266) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/10/2026 3:32 PM | Carter Todd Alfred (1944011) Reporting Voyager Therapeutics (1640266) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/10/2026 3:33 PM | Ferguson Toby (2015616) Reporting Voyager Therapeutics (1640266) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/10/2026 2:11 PM | Carter Todd Alfred (1944011) Reporting Voyager Therapeutics (1640266) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/10/2026 2:17 PM | Swartz Robin (1909636) Reporting Voyager Therapeutics (1640266) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/26/2026 3:05 PM | INTEGRATED CORE STRATEGIES (0) US Voyager Therapeutics (1640266) Subject | Form SCHEDULE 13G | |
| 01/08/2026 5:08 PM | Shiferman Gregory L. (2041689) Reporting Voyager Therapeutics (1640266) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 01/08/2026 5:10 PM | Shiferman Gregory L. (2041689) Reporting Voyager Therapeutics (1640266) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/08/2026 7:16 AM | Voyager Therapeutics (1640266) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/01/2025 11:15 PM | Voyager Therapeutics (1640266) Filer | Form EFFECT | |
| 12/01/2025 3:35 PM | Voyager Therapeutics (1640266) Filer | Form 424B3 | |
| 11/14/2025 5:30 PM | ARMISTICE CAPITAL, LLC (1601086) Filed by Voyager Therapeutics (1640266) Subject | Form SCHEDULE 13G/A | |
| 11/10/2025 7:00 AM | Voyager Therapeutics (1640266) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/10/2025 7:01 AM | Voyager Therapeutics (1640266) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/07/2025 3:30 PM | Jorgensen Nathan D. (1842523) Reporting Voyager Therapeutics (1640266) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/03/2025 4:01 PM | Fahey Sandell Jacquelyn (1984647) Reporting Voyager Therapeutics (1640266) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/02/2025 6:00 AM | Voyager Therapeutics (1640266) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/20/2025 1:09 PM | Ferguson Toby (2015616) Reporting Voyager Therapeutics (1640266) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2025 9:39 AM | Ferguson Toby (2015616) Reporting Voyager Therapeutics (1640266) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/14/2025 8:40 PM | ARMISTICE CAPITAL, LLC (1601086) Filed by Voyager Therapeutics (1640266) Subject | Form SCHEDULE 13G/A | |
| 06/04/2025 7:59 PM | GERAGHTY JAMES A (1239746) Reporting Voyager Therapeutics (1640266) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2025 8:00 PM | Higgins Michael J (1478521) Reporting Voyager Therapeutics (1640266) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
|
| 06/04/2025 8:02 PM | Hyman Steven (1656506) Reporting Voyager Therapeutics (1640266) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2025 8:03 PM | MACKEY CATHERINE J (1645330) Reporting Voyager Therapeutics (1640266) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2025 8:04 PM | Onyia Jude (1894425) Reporting Voyager Therapeutics (1640266) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2025 8:07 PM | PIERCE GLENN (1256964) Reporting Voyager Therapeutics (1640266) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2025 8:08 PM | SCANGOS GEORGE A (1202102) Reporting Voyager Therapeutics (1640266) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2025 8:09 PM | Vitale Nancy (1823262) Reporting Voyager Therapeutics (1640266) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2025 7:58 PM | Colon Grace (1780354) Reporting Voyager Therapeutics (1640266) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/15/2025 2:22 PM | ARMISTICE CAPITAL, LLC (1601086) Filed by Voyager Therapeutics (1640266) Subject | Form SCHEDULE 13G/A | |